Singapore, Singapore

Dorival Mendes Rodrigues-junior

This inventor holds 1 USPTO granted patent. Top assignee: Singapore Health Services Pte Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dorival Mendes Rodrigues-junior. Retrieved from https://idiyas.com/inventor/dorival-mendes-rodrigues-junior

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dorival Mendes Rodrigues-Junior: Innovator in Tyrosine Kinase Inhibition

Introduction

Dorival Mendes Rodrigues-Junior is a notable inventor based in Singapore, SG. He has made significant contributions to the field of medical research, particularly in the modulation of sensitivity to tyrosine kinase inhibitors. His work is crucial for advancing treatment options in various diseases.

Latest Patents

Dorival holds a patent titled "Method of Modulating Sensitivity to Tyrosine Kinase Inhibitor." This patent reflects his innovative approach to enhancing the effectiveness of cancer therapies by targeting specific pathways in cellular processes. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Dorival is currently employed at Singapore Health Services Pte Ltd, where he continues to engage in groundbreaking research. His role at this esteemed institution allows him to collaborate with other experts in the field and contribute to significant advancements in healthcare.

Collaborations

Throughout his career, Dorival has worked alongside talented colleagues, including Fui Teen Chong and Narayanan Gopalakrishna Iyer. These collaborations have fostered a dynamic research environment, leading to innovative solutions in medical science.

Conclusion

Dorival Mendes Rodrigues-Junior exemplifies the spirit of innovation in the medical field. His contributions, particularly in the area of tyrosine kinase inhibitors, highlight the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…